Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

Highlights

  • Highlights
    Selected Articles from This Issue
    Clin Cancer Res April 1 2021 27 (7) 1825-1825;

CCR Translations

  • CCR Translations
    Atezolizumab plus Bevacizumab: A Novel Breakthrough in Hepatocellular Carcinoma
    Florian Castet, Catherine E. Willoughby, Philipp K. Haber and Josep M. Llovet
    Clin Cancer Res April 1 2021 27 (7) 1827-1829; DOI:10.1158/1078-0432.CCR-20-4706

  • CCR Translations
    Pressurized Intraperitoneal Aerosol Chemotherapy: The Road from Promise to Proof
    Loek A.W. de Jong, Nielka P. van Erp and Lana Bijelic
    Clin Cancer Res April 1 2021 27 (7) 1830-1832; DOI:10.1158/1078-0432.CCR-20-4342

  • CCR Translations
    Morning for Irofulven, What Could be fiNER?
    Haoyang Jiang and Roger A. Greenberg
    Clin Cancer Res April 1 2021 27 (7) 1833-1835; DOI:10.1158/1078-0432.CCR-20-4708

CCR Drug Updates

  • CCR Drug Updates
    FDA Approval Summary: Atezolizumab Plus Bevacizumab for the Treatment of Patients with Advanced Unresectable or Metastatic Hepatocellular Carcinoma
    Sandra J. Casak, Martha Donoghue, Lola Fashoyin-Aje, Xiaoping Jiang, Lisa Rodriguez, Yuan-Li Shen, Yuan Xu, Xiling Jiang, Jiang Liu, Hong Zhao, William F. Pierce, Shubhangi Mehta, Kirsten B. Goldberg, Marc R. Theoret, Paul G. Kluetz, Richard Pazdur and Steven J. Lemery
    Clin Cancer Res April 1 2021 27 (7) 1836-1841; DOI:10.1158/1078-0432.CCR-20-3407

  • CCR Drug Updates
    FDA Approval Summary: Alpelisib Plus Fulvestrant for Patients with HR-positive, HER2-negative, PIK3CA-mutated, Advanced or Metastatic Breast Cancer
    Preeti Narayan, Tatiana M. Prowell, Jennifer J. Gao, Laura L. Fernandes, Emily Li, Xiling Jiang, Junshan Qiu, Jianghong Fan, Pengfei Song, Jingyu Yu, Xinyuan Zhang, Bellinda L. King-Kallimanis, Wei Chen, Tiffany K. Ricks, Yutao Gong, Xing Wang, Katherine Windsor, Steve Y. Rhieu, Gerlie Geiser, Anamitro Banerjee, Xiaohong Chen, Francisca Reyes Turcu, Deb K. Chatterjee, Anand Pathak, Jeffrey Seidman, Soma Ghosh, Reena Philip, Kirsten B. Goldberg, Paul G. Kluetz, Shenghui Tang, Laleh Amiri-Kordestani, Marc R. Theoret, Richard Pazdur and Julia A. Beaver
    Clin Cancer Res April 1 2021 27 (7) 1842-1849; DOI:10.1158/1078-0432.CCR-20-3652

  • CCR Drug Updates
    FDA Approval Summary: Accelerated Approval of Sacituzumab Govitecan-hziy for Third-line Treatment of Metastatic Triple-negative Breast Cancer
    Sakar Wahby, Lola Fashoyin-Aje, Christy L. Osgood, Joyce Cheng, Mallorie H. Fiero, Lijun Zhang, Shenghui Tang, Salaheldin S. Hamed, Pengfei Song, Rosane Charlab, Sarah E. Dorff, Tiffany K. Ricks, Kimberly Barnett-Ringgold, Jeannette Dinin, Kirsten B. Goldberg, Marc R. Theoret, Richard Pazdur, Laleh Amiri-Kordestani and Julia A. Beaver
    Clin Cancer Res April 1 2021 27 (7) 1850-1854; DOI:10.1158/1078-0432.CCR-20-3119

Research Briefs: Clinical Trial Brief Reports

  • Research Briefs: Clinical Trial Brief Reports
    Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER+ Breast Cancer
    Giulia Petroni, Aitziber Buqué, Takahiro Yamazaki, Norma Bloy, Maurizio Di Liberto, Selina Chen-Kiang, Silvia C. Formenti and Lorenzo Galluzzi
    Clin Cancer Res April 1 2021 27 (7) 1855-1863; DOI:10.1158/1078-0432.CCR-20-3871

Clinical Trials: Targeted Therapy

  • Clinical Trials: Targeted Therapy
    Preclinical Evaluation and Phase Ib Study of Prexasertib, a CHK1 Inhibitor, and Samotolisib (LY3023414), a Dual PI3K/mTOR Inhibitor
    David S. Hong, Kathleen N. Moore, Johanna C. Bendell, Daniel D. Karp, Judy S. Wang, Susanna V. Ulahannan, Suzanne Jones, Wenjuan Wu, Gregory P. Donoho, Yan Ding, Andrew Capen, Xuejing Wang, Aimee Bence Lin and Manish R. Patel
    Clin Cancer Res April 1 2021 27 (7) 1864-1874; DOI:10.1158/1078-0432.CCR-20-3242

  • Clinical Trials: Targeted Therapy | AuthorChoice
    PIPAC-OX: A Phase I Study of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy in Patients with Peritoneal Metastases
    Guowei Kim, Hon Lyn Tan, Raghav Sundar, Bettina Lieske, Cheng Ean Chee, Jingshan Ho, Asim Shabbir, Maria V. Babak, Wee Han Ang, Boon Cher Goh, Wei Peng Yong, Lingzhi Wang and Jimmy B.Y. So
    Clin Cancer Res April 1 2021 27 (7) 1875-1881; DOI:10.1158/1078-0432.CCR-20-2152

  • Clinical Trials: Targeted Therapy | AuthorChoice
    Phase I Trial of DNA Methyltransferase Inhibitor Guadecitabine Combined with Cisplatin and Gemcitabine for Solid Malignancies Including Urothelial Carcinoma (SPIRE)
    Simon J. Crabb, Sarah Danson, James W.F. Catto, Syed Hussain, Danna Chan, Denise Dunkley, Nichola Downs, Ellice Marwood, Laura Day, Geoff Saunders, Michelle Light, Amy Whitehead, Deborah Ellis, Naveed Sarwar, Deborah Enting, Alison Birtle, Bernadette Johnson, Robert Huddart and Gareth Griffiths
    Clin Cancer Res April 1 2021 27 (7) 1882-1892; DOI:10.1158/1078-0432.CCR-20-3946

  • Clinical Trials: Targeted Therapy
    Clinical Responsiveness to All-trans Retinoic Acid Is Potentiated by LSD1 Inhibition and Associated with a Quiescent Transcriptome in Myeloid Malignancies
    Mina M. Tayari, Helena G. Dos Santos, Deukwoo Kwon, Terrence J. Bradley, Amber Thomassen, Charles Chen, Yvonne Dinh, Aymee Perez, Arthur Zelent, Lluis Morey, Luisa Cimmino, Ramin Shiekhattar, Ronan T. Swords and Justin M. Watts
    Clin Cancer Res April 1 2021 27 (7) 1893-1903; DOI:10.1158/1078-0432.CCR-20-4054

Clinical Trials: Immunotherapy

  • Clinical Trials: Immunotherapy
    Phase I Study of MK-4166, an Anti-human Glucocorticoid-Induced TNF Receptor Antibody, Alone or with Pembrolizumab in Advanced Solid Tumors
    Kyriakos P. Papadopoulos, Karen Autio, Talia Golan, Konstantin Dobrenkov, Elliot Chartash, Qiusheng Chen, Richard Wnek and Georgina V. Long
    Clin Cancer Res April 1 2021 27 (7) 1904-1911; DOI:10.1158/1078-0432.CCR-20-2886

  • Clinical Trials: Immunotherapy | AuthorChoice
    Phase Ib Clinical Trial of IGV-001 for Patients with Newly Diagnosed Glioblastoma
    David W. Andrews, Kevin D. Judy, Charles B. Scott, Samantha Garcia, Larry A. Harshyne, Lawrence Kenyon, Kiran Talekar, Adam Flanders, Kofi-Buaku Atsina, Lyndon Kim, Nina Martinez, Wenyin Shi, Maria Werner-Wasik, Haisong Liu, Mikhail Prosniak, Mark Curtis, Rhonda Kean, Donald Y. Ye, Emily Bongiorno, Sami Sauma, Mark A. Exley, Kara Pigott and D. Craig Hooper
    Clin Cancer Res April 1 2021 27 (7) 1912-1922; DOI:10.1158/1078-0432.CCR-20-3805

  • Clinical Trials: Immunotherapy | AuthorChoice
    Efficacy of Pembrolizumab Monotherapy for Advanced Gastric/Gastroesophageal Junction Cancer with Programmed Death Ligand 1 Combined Positive Score ≥10
    Zev A. Wainberg, Charles S. Fuchs, Josep Tabernero, Kohei Shitara, Kei Muro, Eric Van Cutsem, Yung-Jue Bang, Hyun Cheol Chung, Kensei Yamaguchi, Eniko Varga, Jen-Shi Chen, Daniel Hochhauser, Peter Thuss-Patience, Salah-Eddin Al-Batran, Marcelo Garrido, Uma Kher, Chie-Schin Shih, Sukrut Shah, Pooja Bhagia and Joseph Chao
    Clin Cancer Res April 1 2021 27 (7) 1923-1931; DOI:10.1158/1078-0432.CCR-20-2980

Precision Medicine and Imaging

  • Precision Medicine and Imaging | AuthorChoice
    PET Imaging of TIGIT Expression on Tumor-Infiltrating Lymphocytes
    Travis Shaffer, Arutselvan Natarajan and Sanjiv S. Gambhir
    Clin Cancer Res April 1 2021 27 (7) 1932-1940; DOI:10.1158/1078-0432.CCR-20-2725

  • Precision Medicine and Imaging
    Diffusion-weighted Imaging Allows for Downgrading MR BI-RADS 4 Lesions in Contrast-enhanced MRI of the Breast to Avoid Unnecessary Biopsy
    Paola Clauser, Barbara Krug, Hubert Bickel, Matthias Dietzel, Katja Pinker, Victor-Frederic Neuhaus, Maria Adele Marino, Marco Moschetta, Nicoletta Troiano, Thomas H. Helbich and Pascal A.T. Baltzer
    Clin Cancer Res April 1 2021 27 (7) 1941-1948; DOI:10.1158/1078-0432.CCR-20-3037

  • Precision Medicine and Imaging
    Changes in Diffuse Optical Tomography Images During Early Stages of Neoadjuvant Chemotherapy Correlate with Tumor Response in Different Breast Cancer Subtypes
    Mirella L. Altoe, Kevin Kalinsky, Alessandro Marone, Hyun K. Kim, Hua Guo, Hanina Hibshoosh, Mariella Tejada, Katherine D. Crew, Melissa K. Accordino, Meghna S. Trivedi, Dawn L. Hershman and Andreas H. Hielscher
    Clin Cancer Res April 1 2021 27 (7) 1949-1957; DOI:10.1158/1078-0432.CCR-20-1108

  • Precision Medicine and Imaging
    Imaging Tumor-Infiltrating Lymphocytes in Brain Tumors with [64Cu]Cu-NOTA-anti-CD8 PET
    Veronica L. Nagle, Kelly E. Henry, Charli Ann J. Hertz, Maya S. Graham, Carl Campos, Luis F. Parada, Neeta Pandit-Taskar, Andrea Schietinger, Ingo K. Mellinghoff and Jason S. Lewis
    Clin Cancer Res April 1 2021 27 (7) 1958-1966; DOI:10.1158/1078-0432.CCR-20-3243

  • Precision Medicine and Imaging
    Baseline Circulating Tumor Cell Count as a Prognostic Marker of PSA Response and Disease Progression in Metastatic Castrate-Sensitive Prostate Cancer (SWOG S1216)
    Amir Goldkorn, Catherine Tangen, Melissa Plets, Gareth J. Morrison, Alexander Cunha, Tong Xu, Jacek K. Pinski, Sue A. Ingles, Timothy Triche, Andrea L. Harzstark, Manish Kohli, Gary R. MacVicar, Daniel A. Vaena, Anthony W. Crispino, David J. McConkey, Primo N. Lara Jr, Maha H.A. Hussain, David I. Quinn, Nicholas J. Vogelzang, Ian Murchie Thompson Jr and Neeraj Agarwal
    Clin Cancer Res April 1 2021 27 (7) 1967-1973; DOI:10.1158/1078-0432.CCR-20-3587

  • Precision Medicine and Imaging | AuthorChoice
    VLA4-Targeted Nanoparticles Hijack Cell Adhesion–Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong Survival
    Francesca Fontana, Michael J. Scott, John S. Allen, Xiaoxia Yang, Grace Cui, Dipanjan Pan, Noriko Yanaba, Mark A. Fiala, Julie O'Neal, Anne H. Schmieder-Atteberry, Julie Ritchey, Michael Rettig, Kathleen Simons, Steven Fletcher, Ravi Vij, John F. DiPersio and Gregory M. Lanza
    Clin Cancer Res April 1 2021 27 (7) 1974-1986; DOI:10.1158/1078-0432.CCR-20-2839

  • Precision Medicine and Imaging
    Biomarker Discovery in Patients with Immunotherapy-Treated Melanoma with Imaging Mass Cytometry
    Sandra Martinez-Morilla, Franz Villarroel-Espindola, Pok Fai Wong, Maria I. Toki, Thazin Nwe Aung, Vasiliki Pelekanou, Brian Bourke-Martin, Kurt A. Schalper, Harriet M. Kluger and David L. Rimm
    Clin Cancer Res April 1 2021 27 (7) 1987-1996; DOI:10.1158/1078-0432.CCR-20-3340

Translational Cancer Mechanisms and Therapy

  • Translational Cancer Mechanisms and Therapy
    Targeting Germline- and Tumor-Associated Nucleotide Excision Repair Defects in Cancer
    Sabine Topka, Zoe Steinsnyder, Vignesh Ravichandran, Kaitlyn Tkachuk, Yelena Kemel, Chaitanya Bandlamudi, Mogens Winkel Madsen, Helena Furberg, Ouathek Ouerfelli, Charles M. Rudin, Gopa Iyer, Steven M. Lipkin, Semanti Mukherjee, David B. Solit, Michael F. Berger, Dean F. Bajorin, Jonathan E. Rosenberg, Barry S. Taylor, Elisa de Stanchina, Joseph Vijai and Kenneth Offit
    Clin Cancer Res April 1 2021 27 (7) 1997-2010; DOI:10.1158/1078-0432.CCR-20-3322

  • Translational Cancer Mechanisms and Therapy
    Identification of a Synthetic Lethal Relationship between Nucleotide Excision Repair Deficiency and Irofulven Sensitivity in Urothelial Cancer
    Judit Börcsök, Zsofia Sztupinszki, Raie Bekele, Sizhi P. Gao, Miklos Diossy, Amruta S. Samant, Kasia M. Dillon, Viktoria Tisza, Sándor Spisák, Orsolya Rusz, Istvan Csabai, Helle Pappot, Zoë J. Frazier, David J. Konieczkowski, David Liu, Naresh Vasani, James A. Rodrigues, David B. Solit, Jean H. Hoffman-Censits, Elizabeth R. Plimack, Jonathan E. Rosenberg, Jean-Bernard Lazaro, Mary-Ellen Taplin, Gopa Iyer, Søren Brunak, Rita Lozsa, Eliezer M. Van Allen, Dávid Szüts, Kent W. Mouw and Zoltan Szallasi
    Clin Cancer Res April 1 2021 27 (7) 2011-2022; DOI:10.1158/1078-0432.CCR-20-3316

  • Translational Cancer Mechanisms and Therapy | AuthorChoice
    Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer
    Nina G. Steele, Giulia Biffi, Samantha B. Kemp, Yaqing Zhang, Donovan Drouillard, LiJyun Syu, Yuan Hao, Tobiloba E. Oni, Erin Brosnan, Ela Elyada, Abhishek Doshi, Christa Hansma, Carlos Espinoza, Ahmed Abbas, Stephanie The, Valerie Irizarry-Negron, Christopher J. Halbrook, Nicole E. Franks, Megan T. Hoffman, Kristee Brown, Eileen S. Carpenter, Zeribe C. Nwosu, Craig Johnson, Fatima Lima, Michelle A. Anderson, Youngkyu Park, Howard C. Crawford, Costas A. Lyssiotis, Timothy L. Frankel, Arvind Rao, Filip Bednar, Andrzej A. Dlugosz, Jonathan B. Preall, David A. Tuveson, Benjamin L. Allen and Marina Pasca di Magliano
    Clin Cancer Res April 1 2021 27 (7) 2023-2037; DOI:10.1158/1078-0432.CCR-20-3715

  • Translational Cancer Mechanisms and Therapy | AuthorChoice
    Preclinical Modeling of Surgery and Steroid Therapy for Glioblastoma Reveals Changes in Immunophenotype that are Associated with Tumor Growth and Outcome
    Balint Otvos, Tyler J. Alban, Matthew M. Grabowski, Defne Bayik, Erin E. Mulkearns-Hubert, Tomas Radivoyevitch, Anja Rabljenovic, Sarah Johnson, Charlie Androjna, Alireza M. Mohammadi, Gene H. Barnett, Manmeet S. Ahluwalia, Michael A. Vogelbaum, Peter E. Fecci and Justin D. Lathia
    Clin Cancer Res April 1 2021 27 (7) 2038-2049; DOI:10.1158/1078-0432.CCR-20-3262

  • Translational Cancer Mechanisms and Therapy | AuthorChoice
    PSA-Targeted Alpha-, Beta-, and Positron-Emitting Immunotheranostics in Murine Prostate Cancer Models and Nonhuman Primates
    Darren R. Veach, Claire M. Storey, Katharina Lückerath, Katharina Braun, Christian von Bodman, Urpo Lamminmäki, Teja Kalidindi, Sven-Erik Strand, Joanna Strand, Mohamed Altai, Robert Damoiseaux, Pat Zanzonico, Nadia Benabdallah, Dmitry Pankov, Howard I. Scher, Peter Scardino, Steven M. Larson, Hans Lilja, Michael R. McDevitt, Daniel L.J. Thorek and David Ulmert
    Clin Cancer Res April 1 2021 27 (7) 2050-2060; DOI:10.1158/1078-0432.CCR-20-3614

  • Translational Cancer Mechanisms and Therapy | AuthorChoice
    LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors
    Kelli-Ann Monaco, Scott Delach, Jing Yuan, Yuji Mishina, Paul Fordjour, Emma Labrot, Daniel McKay, Ribo Guo, Stacy Higgins, Hui Qin Wang, Jinsheng Liang, Karen Bui, John Green, Peter Aspesi, Jessi Ambrose, Felipa Mapa, Lesley Griner, Mariela Jaskelioff, John Fuller, Kenneth Crawford, Gwynn Pardee, Stephania Widger, Peter S. Hammerman, Jeffrey A. Engelman, Darrin D. Stuart, Vesselina G. Cooke and Giordano Caponigro
    Clin Cancer Res April 1 2021 27 (7) 2061-2073; DOI:10.1158/1078-0432.CCR-20-2563

  • Translational Cancer Mechanisms and Therapy
    Clinical Proteomics of Metastatic Melanoma Reveals Profiles of Organ Specificity and Treatment Resistance
    Lir Beck, Michal Harel, Shun Yu, Ettai Markovits, Ben Boursi, Gal Markel and Tamar Geiger
    Clin Cancer Res April 1 2021 27 (7) 2074-2086; DOI:10.1158/1078-0432.CCR-20-3752

  • Translational Cancer Mechanisms and Therapy
    Abiraterone Acetate Induces CREB1 Phosphorylation and Enhances the Function of the CBP-p300 Complex, Leading to Resistance in Prostate Cancer Cells
    Wenting Pan, Zhouwei Zhang, Hannah Kimball, Fangfang Qu, Kyler Berlind, Konrad H. Stopsack, Gwo-Shu Mary Lee, Toni K. Choueiri and Philip W. Kantoff
    Clin Cancer Res April 1 2021 27 (7) 2087-2099; DOI:10.1158/1078-0432.CCR-20-4391

  • Translational Cancer Mechanisms and Therapy | AuthorChoice
    A MET Targeting Antibody–Drug Conjugate Overcomes Gemcitabine Resistance in Pancreatic Cancer
    Alex Cazes, Oscar Betancourt, Edgar Esparza, Evangeline S. Mose, Dawn Jaquish, Eric Wong, Alexis A. Wascher, Hervé Tiriac, Marco Gymnopoulos and Andrew M. Lowy
    Clin Cancer Res April 1 2021 27 (7) 2100-2110; DOI:10.1158/1078-0432.CCR-20-3210

  • Translational Cancer Mechanisms and Therapy
    Initial Whole-Genome Sequencing of Plasma Cell Neoplasms in First Responders and Recovery Workers Exposed to the World Trade Center Attack of September 11, 2001
    Francesco Maura, Benjamin Diamond, Kylee H. Maclachlan, Andriy Derkach, Venkata D. Yellapantula, Even H. Rustad, Malin Hultcrantz, Urvi A. Shah, Jessica Hong, Heather J. Landau, Christine A. Iacobuzio-Donahue, Elli Papaemmanuil, Shani Irby, Laura Crowley, Michael Crane, Mayris P. Webber, David G. Goldfarb, Rachel Zeig-Owens, Orsi Giricz, Amit Verma, David J. Prezant, Ahmet Dogan, Sohrab P. Shah, Yanming Zhang and Ola Landgren
    Clin Cancer Res April 1 2021 27 (7) 2111-2118; DOI:10.1158/1078-0432.CCR-20-2245

Letters to the Editor

  • Letters to the Editor | AuthorChoice
    Outcomes of Oral Vinorelbine in Progressive Desmoid Fibromatosis—Letter
    Chuanxi Zheng, Li Min and Chongqi Tu
    Clin Cancer Res April 1 2021 27 (7) 2119-2119; DOI:10.1158/1078-0432.CCR-20-4755

  • Letters to the Editor
    Outcomes of Oral Vinorelbine in Progressive Desmoid Fibromatosis—Response
    Olivier Mir, Charles Honoré, Ali N. Chamseddine, Matthieu Faron, Leila Haddag-Miliani, Arnaud Bayle and Axel Le Cesne
    Clin Cancer Res April 1 2021 27 (7) 2120-2120; DOI:10.1158/1078-0432.CCR-21-0041

Back to top
PreviousNext
Clinical Cancer Research: 27 (7)
April 2021
Volume 27, Issue 7
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Editorial Board (PDF)

Sign up for alerts

Issue Highlights

  • Preclinical Evaluation and Phase Ib Study of Prexasertib, a CHK1 Inhibitor, and Samotolisib (LY3023414), a Dual PI3K/mTOR Inhibitor
  • Phase I Study of MK-4166, an Anti-human Glucocorticoid-Induced TNF Receptor Antibody, Alone or with Pembrolizumab in Advanced Solid Tumors
  • PET Imaging of TIGIT Expression on Tumor-Infiltrating Lymphocytes
  • Targeting Germline- and Tumor-Associated Nucleotide Excision Repair Defects in Cancer

Jump to

  • Highlights
  • CCR Translations
  • CCR Drug Updates
  • Research Briefs: Clinical Trial Brief Reports
  • Clinical Trials: Targeted Therapy
  • Clinical Trials: Immunotherapy
  • Precision Medicine and Imaging
  • Translational Cancer Mechanisms and Therapy
  • Letters to the Editor
Advertisement
  • Most Cited
  • Most Read
Loading
  • scRNA-seq Analysis of Gastric Cancer TME
  • Toxicity Management Affects Checkpoint Inhibitor Efficacy
  • PDAC and GATA6 Expression
  • Rucaparib in mCRPC with a Non-BRCA DDR Gene Alteration
  • AR Gene Rearrangements in Prostate Cancer
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement